全文获取类型
收费全文 | 41933篇 |
免费 | 2231篇 |
国内免费 | 204篇 |
专业分类
耳鼻咽喉 | 381篇 |
儿科学 | 825篇 |
妇产科学 | 687篇 |
基础医学 | 5287篇 |
口腔科学 | 1028篇 |
临床医学 | 2829篇 |
内科学 | 10256篇 |
皮肤病学 | 847篇 |
神经病学 | 2942篇 |
特种医学 | 1512篇 |
外科学 | 7795篇 |
综合类 | 392篇 |
一般理论 | 6篇 |
预防医学 | 1453篇 |
眼科学 | 526篇 |
药学 | 2972篇 |
中国医学 | 143篇 |
肿瘤学 | 4487篇 |
出版年
2023年 | 236篇 |
2022年 | 417篇 |
2021年 | 781篇 |
2020年 | 470篇 |
2019年 | 623篇 |
2018年 | 769篇 |
2017年 | 597篇 |
2016年 | 696篇 |
2015年 | 780篇 |
2014年 | 994篇 |
2013年 | 1158篇 |
2012年 | 1815篇 |
2011年 | 1950篇 |
2010年 | 1067篇 |
2009年 | 898篇 |
2008年 | 1684篇 |
2007年 | 1813篇 |
2006年 | 1818篇 |
2005年 | 1838篇 |
2004年 | 1866篇 |
2003年 | 1778篇 |
2002年 | 1777篇 |
2001年 | 1761篇 |
2000年 | 1719篇 |
1999年 | 1638篇 |
1998年 | 566篇 |
1997年 | 469篇 |
1996年 | 415篇 |
1995年 | 368篇 |
1994年 | 373篇 |
1993年 | 331篇 |
1992年 | 1044篇 |
1991年 | 976篇 |
1990年 | 846篇 |
1989年 | 942篇 |
1988年 | 808篇 |
1987年 | 749篇 |
1986年 | 783篇 |
1985年 | 711篇 |
1984年 | 456篇 |
1983年 | 387篇 |
1982年 | 201篇 |
1981年 | 188篇 |
1979年 | 323篇 |
1978年 | 249篇 |
1977年 | 212篇 |
1975年 | 212篇 |
1974年 | 192篇 |
1973年 | 181篇 |
1971年 | 178篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Mitsuhashi N Tanaka Y Kubo S Ogawa S Hayashi C Uchino H Shimizu T Watada H Kawasumi M Onuma T Kawamori R 《Endocrine journal》2004,51(6):545-550
The aim of this study was to investigate the effect of cilostazol, a cAMP phosphodiesterase inhibitor, on carotid artery intima-media thickness (IMT) and on the incidence of cardiovascular events in Japanese subjects with type 2 diabetes. A total of 62 type 2 diabetic subjects were allocated equally to the cilostazol treatment group (n = 31) and the control group (n = 31). Carotid IMT was evaluated before and after treatment using B-mode ultrasonography. After the study period (mean +/- SD: 2.6 +/- 0.17 years), carotid IMT showed a significantly greater increase in the control group than in the cilostazol group (0.12 +/- 0.14 mm vs. 0.04 +/- 0.02 mm, p < 0.05). In the control group, 1 out of 31 patients suffered from symptomatic cerebral infarction and 1 had angina pectoris during the observation period. On the other hand, no subject in the cilostazol group developed cardiovascular events during the study period. At baseline, the diabetic patients given cilostazol had a significantly lower HbA1c level than the control subjects, but the other atherosclerotic risk factors (BMI, blood pressure, and serum lipids) and the duration of diabetes did not differ between the two groups. These results indicate that cilostazol therapy can attenuate the increase of carotid artery IMT in Japanese subjects with type 2 diabetes. 相似文献
992.
993.
Iwata T Inoue K Mizuguchi S Morita R Tsukioka T Tanaka H Suehiro S 《Respirology (Carlton, Vic.)》2008,13(4):619-620
Abstract: A 61-year-old woman presented with chest pain. Chest CT revealed a mass of 6 cm diameter in the right lower lobe. Bronchoscopic biopsy showed squamous cell carcinoma. Video-assisted thoracotomy revealed that the main tumour was directly invading the liver through the diaphragm. To alleviate local symptoms and for possible cure with adjuvant chemotherapy and radiotherapy, standard right lower lobectomy and mediastinal dissection were carried out, followed by combined resection of the diaphragm and posterior superior segmentectomy of the liver. Eleven months postoperatively, the patient was alive but had a metastatic lesion in the other lobe of the liver which reduced in size following chemotherapy. 相似文献
994.
995.
Ultrasonographic evaluation of lansoprazole-induced improvement of submucosal injury in patients with gastroesophageal reflux 总被引:2,自引:0,他引:2
Mine S Fujisaki T Tabata T Matsuoka H Iida T Yamada S Tanaka Y Morimoto I Eto S Aibe T 《The American journal of gastroenterology》2000,95(2):381-386
OBJECTIVE: Endoscopic ultrasonographic (EUS) changes in gastroesophageal reflux disease (GERD) after treatment with proton pump inhibitor have been poorly evaluated. We conducted a randomized, double-blind 12-wk clinical trial to compare the EUS effects of lansoprazole to histamine H2-receptor antagonist therapy in GERD. METHODS: Seventeen patients with reflux-related symptoms received 40 mg of famotidine for 6 wk or 30 mg of lansoprazole for 6 wk followed by 40 mg of famotidine or 30 mg of lansoprazole for another 6 wk, respectively. Patients underwent EUS before and at 6 and 12 wk after treatment. RESULTS: Before treatment, a variable degree of wall thickening was noted on EUS in the lower esophagus, compared with 20 normal subjects. After 6 wk of therapy, esophageal wall was significantly thicker in the famotidine group compared with the lansoprazole group (p<0.01). Surprisingly, thickening of esophageal wall and abnormal architecture were also detected in endoscopically negative reflux disease. Lansoprazole was superior to famotidine in reducing the thickness of esophageal wall. CONCLUSIONS: EUS was very useful for evaluation of submucosal injury in patients with GERD. EUS showed that a 6-wk course of lansoprazole therapy reduced thickening of esophageal wall, which was resistant to histamine H2-receptor antagonist therapy. Our results also suggest that inflammatory damage to the submucosal and muscle layers of the lower esophagus is the underlying mechanism of heartburn and associated symptoms in patients with endoscopically negative reflux disease. 相似文献
996.
Severe exacerbation of hepatitis after short-term corticosteroid therapy in a patients with "latent" chronic hepatitis B 总被引:2,自引:0,他引:2
Shiota G Harada K Oyama K Udagawa A Nomi T Tanaka K Tsutsumi A Noguchi N Kishimoto Y Horie Y Suou T Kawasaki H 《Liver》2000,20(5):415-420
We present a case of severe exacerbation of hepatitis after short-term corticosteroid therapy for chronic inflammatory demyelinating polyneuropathy (CIPD) with "latent" chronic hepatitis B showing no HBV-related antigens and antibodies. After corticosteroid pulse therapy for CIPD, the patient had severe exacerbation of hepatitis twice. Although she did not show any hepatitis B virus (HBV)-related antigens or antibodies, sequences of HBV were detected in serum and liver by a nested polymerase chain reaction. A sequence analysis of HBV at the second exacerbation showed that the G-to-A point mutation at nucleotide 1896 that converted codon 28 from tryptophan (TGG) to a stop codon (TAG) in the precore region resulted in amino acid change, which has been frequently observed in fulminant hepatitis and severe hepatitis in Japan. 相似文献
997.
Kaneki T Kawashima A Akamatsu T Tanaka N Kubo K Koizumi T Sekiguchi M Hosaka N Honda T Koike S Adachi W 《Journal of gastroenterology》1999,34(2):253-259
We report a rare case of immunoblastic lymphadenopathy (IBL)-like T-cell lymphoma complicated by multiple gastrointestinal
involvement, which appeared to be ameliorated by chemotherapy but resulted in perforative peritonitis. A 66-year-old Japanese
woman who had generalized lymphadenopathy and eruptions was admitted to our hospital because of bloody stool. Colonoscopic
examination revealed hemorrhagic ulcers in the terminal ileum and a saucer-like ulcer in the cecum. Gastrointestinal endoscopy
revealed several ulcerative or elevated lesions in stomach and duodenum. Biopsy specimens of these lesions and of a lymph
node showed characteristic histological features of IBL-like T-cell lymphoma. The initial treatment with prednisolone (PSL)
and cyclophosphamide (CPA) was effective. Six months after the treatment, however, she developed bloody stool again caused
by multiple ulcerative lesions in the large intestine. The recurrence of the disease was determined histologically, and four
courses of CPA, PSL, vinblastine sulfate and doxorubicin hydrochloride (CHOP) therapy were administered. One month after completing
the CHOP therapy, she developed intestinal obstruction and then acute peritonitis resulting from perforation at an ulcer scar
in the jejunum. Surgical treatment was successful, and histological examination demonstrated no lymphoma cells in the resected
specimen. A gastrointestinal perforation should be recognized as a potential complication of IBL-like T-cell lymphoma, even
during remission.
(Received: June 24, 1998; accepted: Oct. 23, 1998) 相似文献
998.
Torahiko Takeda Hiroki Tohma Junichi Yoshida Gen Naritomi Hiroyuki Konomi Zhou-Lu Deng Naoko Kinukawa Masao Tanaka 《Journal of gastroenterology》1998,33(6):860-863
The relationship between sphincter of Oddi pressure and the morphological structure of the sphincter was studied in eight
dogs prepared with a duodenal cannula. Sphincter of Oddi manometry was performed in awake animals in three directions, ventral,
left dorsal, and right dorsal, using a catheter with three radial side holes for recording at one level. The pressure in the
ventral direction (26.6 ± 1.06 mmHg) (mean ± SEM) was significantly lower than that in the left and right dorsal directions
(30.6 ± 1.42 and 31.2 ± 1.23 mmHg, respectively). This functional manometric difference in the three directions correlated
closely with the morphological structure of the sphincter of Oddi; the sum of the thickness of the sphincter of Oddi muscle
and duodenal proper muscle was greater on the dorsal than on the ventral side. To our knowledge, this is the first report
of axial asymmetry in sphincter of Oddi pressure.
(Received May 27, 1997; accepted April 24, 1998) 相似文献
999.
1000.
Toshio Tsuyuguchi Tadahiro Takada Yoshifumi Kawarada Yuji Nimura Keita Wada Masato Nagino Toshihiko Mayumi Masahiro Yoshida Fumihiko Miura Atsushi Tanaka Yuichi Yamashita Masahiko Hirota Koichi Hirata Hideki Yasuda Yasutoshi Kimura Horst Neuhaus Steven Strasberg Henry Pitt Jacques Belghiti Giulio Belli John A. Windsor Miin-Fu Chen Sun-Whe Kim Christos Dervenis 《Journal of hepato-biliary-pancreatic sciences》2007,14(1):46-51
The principal management of acute cholecystitis is early cholecystectomy. However, percutaneous transhepatic gallbladder drainage (PTGBD) may be preferable for patients with moderate (grade II) or severe (grade III) acute cholecystitis. For patients with moderate (grade II) disease, PTGBD should be applied only when they do not respond to conservative treatment. For patients with severe (grade III) disease, PTGBD is recommended with intensive care. Percutaneous transhepatic gallbladder aspiration (PTGBA) is a simple alternative drainage method with fewer complications; however, its clinical usefulness has been shown only by case-series studies. To clarify the clinical value of these drainage methods, proper randomized trials should be done. This article describes techniques of drainage for acute cholecystitis. 相似文献